Website
N/ATelephone
61.1300.110.366
Address
Level 8 525 Flinders Street Melbourne, Victoria (VIC) 3000
Description
Careteq Ltd. engages in the development, design, and commercialization of assisted-living technology products. It operates through the following segments: CARETEQ Limited, CARETEQ International Incorporated, and Ward Health Group. The CARETEQ Limited segment focuses on sale and distribution agreements within Australia and New Zealand that offers SofiHub, TEQ Home, TEQ Square, and eazense products and services. The CARETEQ International Incorporated includes the sales and distribution agreements within the United States of America. The Ward Health Group segment offers provision of clinical pharmacy services to aged care in Australia. The company was founded by Elizabeth Crooks, Ian Aitken, and Steve Stapelberg in 2016 and is headquartered in Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.02 - 0.06
Trade Value (12mth)
AU$1,213.00
1 week
-8%
1 month
-23.33%
YTD
-62.36%
1 year
-57.51%
All time high
0.165873
EPS 3 yr Growth
98.700%
EBITDA Margin
-58.50%
Operating Cashflow
-$3m
Free Cash Flow Return
-58.70%
ROIC
-100.20%
Interest Coverage
-214.10
Quick Ratio
1.10
Shares on Issue (Fully Dilluted)
142m
HALO Sector
Industrials
Next Company Report Date
05-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 23 |
CTQ Q1-FY24 ACTIVITIES REPORT & APPENDIX 4C
×
CTQ Q1-FY24 ACTIVITIES REPORT & APPENDIX 4C |
31 October 23 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
31 July 23 |
CTQ Q4-FY23 ACTIVITIES REPORT & APPENDIX 4C
×
CTQ Q4-FY23 ACTIVITIES REPORT & APPENDIX 4C |
31 August 23 |
Careteq - Full Year Results
×
Careteq - Full Year Results |
31 August 23 |
Careteq - Full Year Results Presentation
×
Careteq - Full Year Results Presentation |
30 November 23 |
Careteq AGM Presentation
×
Careteq AGM Presentation |
30 November 23 |
Results of Meeting
×
Results of Meeting |
30 November 23 |
New Constitution
×
New Constitution |
30 June 23 |
Retraction of Statements in March 2023 Qtrly Activity Report
×
Retraction of Statements in March 2023 Qtrly Activity Report |
30 June 23 |
Response to ASX Query
×
Response to ASX Query |
30 August 23 |
Careteq - Appendix 4E
×
Careteq - Appendix 4E |
30 August 23 |
Careteq 2023 Annual Report
×
Careteq 2023 Annual Report |
30 August 23 |
Careteq - Appendix 4G
×
Careteq - Appendix 4G |
30 August 23 |
Careteq Corporate Governance Statement
×
Careteq Corporate Governance Statement |
29 November 22 |
Careteq - AGM Presentation
×
Careteq - AGM Presentation |
29 November 22 |
Results of Meeting
×
Results of Meeting |
29 May 23 |
Change of Director's Interest Notice and Substantial Holding
×
Change of Director's Interest Notice and Substantial Holding |
29 July 22 |
CTQ Q4-FY22 ACTIVITIES REPORT & APPENDIX 4C
×
CTQ Q4-FY22 ACTIVITIES REPORT & APPENDIX 4C |
29 April 22 |
Clarification of Appendix 3X & Appendix 3Y - M Simari
×
Clarification of Appendix 3X & Appendix 3Y - M Simari |
29 April 22 |
3Q-FY22 ACTIVITIES REPORT & APPENDIX 4C
×
3Q-FY22 ACTIVITIES REPORT & APPENDIX 4C |
28 October 22 |
CTQ Q1-FY23 ACTIVITIES REPORT & APPENDIX 4C
×
CTQ Q1-FY23 ACTIVITIES REPORT & APPENDIX 4C |
28 February 23 |
Change of Director's Interest Notice and Substantial Holding
×
Change of Director's Interest Notice and Substantial Holding |
28 February 22 |
Appendix 4D & Half Year Results
×
Appendix 4D & Half Year Results |
28 February 22 |
Half Year Results Presentation
×
Half Year Results Presentation |
28 April 23 |
CTQ Q3-FY23 ACTIVITIES REPORT & APPENDIX 4C
×
CTQ Q3-FY23 ACTIVITIES REPORT & APPENDIX 4C |
27 July 23 |
Results of Institutional Entitlement Offer
×
Results of Institutional Entitlement Offer |
27 January 22 |
Change of Director's Interest Notice - B Cheong
×
Change of Director's Interest Notice - B Cheong |
26 October 22 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.